Manuel Alba Sells 183,000 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the transaction, the director owned 319,863 shares in the company, valued at $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $117.14 on Friday. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The stock has a 50-day moving average price of $131.56 and a 200 day moving average price of $159.09. The stock has a market capitalization of $20.06 billion, a P/E ratio of 96.02, a P/E/G ratio of 2.31 and a beta of 1.78.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same period in the previous year, the firm earned $0.37 EPS. The firm’s revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Loop Capital assumed coverage on shares of Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 target price for the company. Citigroup started coverage on shares of Astera Labs in a report on Thursday. They set a “buy” rating and a $200.00 price objective for the company. Northland Securities raised their price objective on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Barclays set a $165.00 target price on Astera Labs in a research report on Thursday, January 15th. Finally, Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Fifteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $199.44.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Citi initiated/maintained a Buy and set a $200 price target on ALAB, highlighting PCIe and AI-infrastructure opportunity — a sizable analyst endorsement that can lift sentiment and buying interest. Benzinga Coverage
• Positive Sentiment: Research notes (TipRanks summary) underscore Astera Labs’ PCIe switch leadership and positioning in rack-scale AI connectivity, framing multiyear revenue upside tied to data-center AI buildouts. Astera Labs: Leveraging PCIe Switch Leadership…
• Positive Sentiment: Astera appears on roundups of leading growth stocks with notable insider ownership — a signal some investors use to judge management alignment and conviction, which can support valuation multiple expansion if execution continues. April 2026’s Leading Growth Stocks With Insider Ownership
• Neutral Sentiment: Company announced it will report Q1 2026 results after market close on May 5 and hold a conference call — an imminent catalyst that could swing the stock depending on revenue, margins and guidance. Astera Labs Announces Conference Call…
• Negative Sentiment: Recent articles flag a ~36% YTD decline and call out margin pressure and intensifying competition as key near-term risks; these concerns help explain the share-price pullback despite top-line AI/PCIe tailwinds. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD?
• Negative Sentiment: Analyst commentary and newsletter pieces emphasize margin compression risks even as demand grows — if margins miss or competition accelerates, upside expectations tied to AI/PCIe could be delayed. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD? (Zacks)

Institutional Trading of Astera Labs

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. grew its position in Astera Labs by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after acquiring an additional 84,365 shares in the last quarter. State Street Corp raised its position in Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the period. Geode Capital Management LLC raised its position in Astera Labs by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares during the period. Fred Alger Management LLC lifted its stake in shares of Astera Labs by 25.5% in the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after purchasing an additional 393,250 shares during the last quarter. Finally, Morgan Stanley lifted its stake in shares of Astera Labs by 33.0% in the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock valued at $321,818,000 after purchasing an additional 480,009 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.